Dr. Remberto Martis
Dr. Remberto Martis is a co-founder and Chief Executive Officer of LenioBio GmbH. Remberto previously led the M&A group of Mitsubishi Chemical Holding responsible for technology transfer and the acquisition of European life science start-ups and their integration within the company.
His career started as a brand manager at Proctor & Gamble in New York, responsible for several brands in personal care. Remberto has held a position in Philips where he had a variety of technology development, licensing and corporate development roles. During his time at Philips he learned the Japanese language, worked and lived in Taiwan, Hong Kong and Shanghai and established his extensive network in Asia and the US.
Remberto received a BSc in Biomolecular Engineering the Fontys University of Applied Sciences (The Netherlands), MSc in Process Engineering from the Eindhoven University of Technology and a PhD in Life Science and Technology from the Delft University of Technology.
Dr. Hákon Birgisson
Dr. Hákon Birgisson is a co-founder and Chief Commercial Officer of LenioBio GmbH. Hákon previously held a position as Director of Global Market Development at the ORF Genetics in Iceland.
Before that he was at Biotage AB in Sweden working on Global Marketing and Merger & Acquisitions. He has also worked in investment banking as a fund manager of global equities, in a CRO conducting clinical trials and as a research scientist in protein chemistry.
Hákon received a BSc in Biochemistry from the University of Iceland, a PhD in Biotechnology from the University of Lund and a MBA from Reykjavik University.